(Q43904258)

27 November 2017

title

Randomized, controlled trial of recombinant human interleukin-11 in patients with active Crohn's disease (English)

1 reference

randomized controlled trial

27 November 2017

1 reference

1 reference

B E Sands

1

1 reference

27 November 2017

B D Winston

2

1 reference

27 November 2017

B Salzberg

3

1 reference

27 November 2017

M Safdi

4

1 reference

27 November 2017

C Barish

5

1 reference

27 November 2017

L Wruble

6

1 reference

27 November 2017

R Wilkins

7

1 reference

27 November 2017

M Shapiro

8

1 reference

27 November 2017

U S Schwertschlag

9

1 reference

27 November 2017

RHIL-11 Crohn's Study group

10

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

Alimentary Pharmacology & Therapeutics

27 November 2017

published in

1 reference

27 November 2017

volume

16

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

399-406

1 reference

Inflammatory bowel disease: etiology and pathogenesis

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01179.X

Treatment of inflammatory bowel disease from now to the millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01179.X

Proinflammatory cytokines differentially modulate their own expression in human intestinal mucosal mesenchymal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01179.X

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01179.X

gp130 transducing receptor cross-linking is sufficient to induce interleukin-6 type responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01179.X

Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01179.X

Intestinal permeability of 51Cr-labelled ethylenediaminetetraacetic acid in patients with Crohn's disease and their healthy relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01179.X

Importance of intestinal mucosal immunity and luminal bacterial cell wall polymers in the aetiology of inflammatory joint diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01179.X

Pharmacokinetics of recombinant human interleukin-11 (rhIL-11) in healthy male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01179.X

10.1046/J.1365-2036.2002.01179.X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference